CTA-PB

Business Context and Reporting Period

Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1996
Business Overview: DuPont operates across Chemicals, Fibers, Polymers, Petroleum, and Diversified Businesses. The quarter reflects a difficult global business climate for chemicals and specialties, contrasted with higher earnings in the Petroleum segment due to increased crude oil prices and natural gas volumes.

Key Financial Metrics

Dividends: $0.52 per share paid in Q1 1996. The company announced an increase to $0.57 per share effective Q2 1996.

Material Changes vs. Prior Period

• Earnings Per Share: Increased 12% to $1.57 from $1.40, driven primarily by an 18% reduction in average shares outstanding following the 1995 stock redemption from Seagram.
• Net Income: Decreased 8% to $879 million from $959 million. Excluding nonrecurring items and specific interest expenses, earnings were roughly flat compared to the prior year.
• Sales Growth: Total sales rose 3% to $10.8 billion. Petroleum sales increased 9% ($4.7 billion), while Chemicals and Specialties sales declined 2% ($6.1 billion) due to lower volumes offsetting higher prices.
• Cash Flow: Operating cash flow declined 23% to $761 million, attributed to lower net income and higher undistributed earnings from affiliates.
• Segment Performance:
  • Petroleum: Earnings up 21% to $214 million.
  • Diversified Businesses: Earnings up 20% to $283 million.
  • Polymers: Earnings down 15% to $198 million due to capacity expansion costs and the GM strike.
  • Fibers: Earnings down 11% to $179 million due to weakness in U.S. textile production.
  • Chemicals: Earnings down 13% to $143 million.

Guidance, Outlook, and Risks

Management Commentary and Outlook

• Capital Expenditures: Expected to total approximately $3.8 billion for the full year 1996.
• Debt Reduction: Management aims to reduce the debt ratio to approximately 45% by year-end 1996 through internally generated funds and roughly $2 billion in asset sales (including Medical Products and an elastomers joint venture with Dow Chemical).
• Market Conditions: Chemicals and specialties continue to face a difficult global climate with volumes 5% below the prior year's record first quarter.

Risks and Contingencies

• Legal Proceedings (Benlate): Over 700 lawsuits filed by growers alleging crop damage from "Benlate" 50 DF fungicide. Approximately 80 remain active. DuPont maintains the product did not cause damage. Accruals are recorded, but adverse changes in estimates could result in additional charges.
• Legal Proceedings (Polybutylene): Approximately 100 homeowner lawsuits regarding plumbing leaks. DuPont is a codefendant and has agreed to contribute 10% of repair costs up to a $120 million cap.
• Environmental: Pending penalties and settlements regarding refinery waste management (Conoco) and Clean Water Act violations (Edge Moor Plant). A pipeline discharge complaint by the DOJ against a subsidiary (Yellowstone Pipeline) seeks penalties exceeding $100,000.

Unusual Items

• Nonrecurring Charges: $53 million after-tax ($0.10 per share) for employee separations.
• Nonrecurring Benefits: $33 million ($0.06 per share) related to the sale of stock from the previously sold connector systems business.

Investor Verification Checklist

• Share Count Impact: Verify the 18% reduction in average shares outstanding and its specific contribution to the EPS increase.
• Asset Sales Progress: Monitor the execution of the planned $2 billion in asset sales required to meet the 45% debt ratio target.
• Legal Exposure: Review the status of the "Benlate" litigation and the potential for costs to exceed current accruals.
• Volume Trends: Assess the sustainability of the 5% volume decline in the Chemicals and Specialties segment.
• Capital Allocation: Confirm the $3.8 billion capital expenditure plan aligns with cash flow generation capabilities.